LYRIC Polyclonal Antibody, Cy5 Conjugated from Bioss Inc.

Supplier Page

Supplier Page from
Bioss Inc. for
LYRIC Polyclonal Antibody, Cy5 Conjugated

Bioss Inc.'s LYRIC Polyclonal Antibody, Cy5 Conjugated is a Rabbit Polyclonal antibody. This antibody has been shown to work in applications such as: Flow Cytometry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunohistochemistry - fixed, Immunohistochemistry - frozen, and Western Blot. The LYRIC Polyclonal Antibody, Cy5 Conjugated was generated using Metadherin, and MTDH as the antigen and it reacts with Homo Sapiens, and Human.

Description

Downregulates SLC1A2/EAAT2 promoter activity when expressed ectopically. Activates the nuclear factor kappa-B (NF-kappa-B) transcription factor. Promotes anchorage-independent growth of immortalized melanocytes and astrocytes which is a key component in tumor cell expansion. Promotes lung metastasis and also has an effect on bone and brain metastasis, possibly by enhancing the seeding of tumor cells to the target organ endothelium. Induces chemoresistance